Related Experiment Video
Updated: Jan 9, 2026
08:22
IR-TEx: An Open Source Data Integration Tool for Big Data Transcriptomics Designed for the Malaria Vector Anopheles gambiae
Published on: January 15, 2020
6.6K
Insect UDP-glycosyltransferases and xenobiotic metabolism.
1Department of Entomology, Comstock Hall, Cornell University, Ithaca, NY 14853, USA.
Pesticide Biochemistry and Physiology
|December 1, 2025
Summary
UDP-glycosyltransferases (UGTs) are key enzymes in insects for detoxifying foreign compounds. This review summarizes 39 studies, highlighting their roles in xenobiotic metabolism and identifying areas for future research.
Area of Science:
- Biochemistry
- Toxicology
- Entomology
Background:
- UDP-glycosyltransferases (UGTs) are crucial enzymes found in all organisms.
- They conjugate xenobiotics with sugars, increasing water solubility for excretion.
- Insect UGTs play a significant role in metabolizing foreign compounds.
Purpose of the Study:
- To review recent research on insect UGTs and their involvement in xenobiotic detoxification.
- To analyze findings from 39 studies across over 20 insect and mite species.
- To identify patterns, data gaps, and future research directions in insect UGTs.
Main Methods:
- Literature review of 39 studies on insect UGTs.
- Analysis of xenobiotic metabolism associated with specific UGTs.
- Inclusion of data on over 30 xenobiotic substrates.
Main Results:
- Demonstrated xenobiotic metabolism linked to specific UGTs in insects and mites.
- Observed relatively modest phenotypes when using RNA interference (RNAi) to study UGT function.
- Identified over 30 xenobiotics as potential substrates for insect UGTs.
Conclusions:
- Insect UGTs are vital for xenobiotic detoxification, though RNAi studies show modest effects.
- Significant progress has been made, but data gaps remain in understanding UGT function.
- Further research is needed to fully elucidate the roles and substrate specificities of insect UGTs.
More Related Videos
Related Concept Videos
01:24Phase II Reactions: Glucuronidation
1.6K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.6K
01:14Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
01:16Drug Biotransformation: Overview
3.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.5K
01:28Drug Biotransformation: Overview
2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K
01:06Carrier-Mediated Transport
981
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
981
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
161
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
161